ÂÜÀòÂÒÂ×

Olivija Sileike is a seasoned professional in business development and pharmaceutical services, currently serving as the Director of Business Development at PrimeVigilance since July 2023. Additionally, Sileike is a Board Member of the Lithuanian Pharmaceutical Association since November 2022. Prior experience includes a significant tenure at Biomapas from November 2016 to May 2023, where Sileike held various roles, including Associate Director of Business Development, focusing on regulatory affairs and pharmacovigilance. Sileike's earlier career involved roles ranging from Business Development Associate to Assistant, demonstrating a strong trajectory in client management and proposal development. Education credentials encompass a Master's degree in International Business from Kaunas University of Technology and a Master's degree in Pharmacy from the Lithuanian University of Health Sciences, complemented by studies at the University of Montpellier.